AMLX — Amylyx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Amylyx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12.9	96.1	347	371	177
Net Total Accounts Receivable
Net Total Receivables	—	—	15.3	40	0.447
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13.6	105	382	465	189
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.151	0.474	8.13	6.41	2.73
Other Long Term Assets
Total Assets	14.1	106	391	517	194
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	7.33	17.4	46.6	82	28.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.77	17.4	50.8	84	28.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.34	88.2	341	433	165
Total Liabilities & Shareholders' Equity	14.1	106	391	517	194
Total Common Shares Outstanding
Total Preferred Shares Outstanding